Trend Report

Social Computing Strategy For Life Sciences Firms

Chloe Stromberg
 and  three contributors
Jul 18, 2007

Summary

Like it or not, Social Computing is coming to the life sciences industry. If you don't believe us, check out the YouTube video of a purported Eli Lilly sales rep dishing ZYPREXA's side effects or read the passionate consumer comments on GlaxoSmithKline's AlliConnect blog. Harnessing social media promises big benefits like improving consumer trust in brands, but it also brings formidable risks like adverse event reporting complexity driven by consumer comments in forums and blogs. To navigate the unknown waters of social media safely, life sciences firms must take four steps: 1) educate executives and legal; 2) identify internal innovators and existing learning; 3) build a task force; and 4) anticipate organizational change and internal resource demands to arrive at a sensible strategy.

Log in to continue reading
Client log in
Welcome back. Log in to your account to continue reading this research.
Become a client
Become a client today for these benefits:
  • Stay ahead of changing market and customer dynamics with the latest insights.
  • Partner with expert analysts to make progress on your top initiatives.
  • Get answers from trusted research using Izola, Forrester's genAI tool.
Purchase this report
This report is available for individual purchase ($1495).